Portfoliotracker

Syn2bio S.A.

S2B.WA · WARSAW · Healthcare Biotechnology

59,68 PLN
▼ −2,14 (−3,46 %)
Trading
Price as of 17. 11. 14:07, fetched 17. 11. 14:22
Next earnings–
Ex-dividend–
Analysts–
50 / 200 day average– / –

Price

Portfoliotracker score– Market cap540 mil. PLN P/E– Forward P/E– P/S– P/B16 060,8 EV/EBITDA– Dividend yield– FCF yield-3,91 % EPS-2,81 PLN Net margin0,0 % Return on equity– Beta– Debt / equity–
52-week range 26,20 to 96,60
3-month average volume0,0 M

Finance

Where the revenue goes

Loading the income statement flow…

Fundamentals

Loading key figures…

Insiders, analysts and people

All trades and changes

Loading insiders, analysts and opinions…

Co se právě děje

AI souhrn
Objednat AI souhrn, co se u firmy právě děje Vytvoří se jednou na pozadí a pak ho uvidí všichni. Ve verzi Free 3 objednávky měsíčně.

About the company

Syn2bio S.A. operates as a biotechnology company. It engages in the development and commercialization of SYN2 cardiotracer, a radiopharmaceutical designed for testing myocardial perfusion and diagnosis of coronary artery disease. It is also engages in the research of new pharmaceutical compounds and its further study, registration, and market launch as a medicinal product. Syn2bio S.A. was incorporated in 2025 and is based in Warsaw, Poland.

Country
Poland
Data since
16. 4. 2026

Explore further

Similar companies SNT.WAXTB.WACBF.WAKRU.WADIG.WA

Intraday chart

Your own portfolio, properties and finances in one place.

The account is free with no time limit. Only you see your data; nobody adds it up with others.

This is saved to your account. You can keep browsing, calculating and comparing without signing in.

Welcome back

Sign in and pick up where you left off.

or continue with

No account yet? Create a free account